Back
Intellia Therapeutics Vs. BridgeBio Pharma Industry Stock Comparison
Sell
27
NTLA
Intellia Therapeutics
Last Price:
22.06
Seasonality Move:
1.88%
Sell
42
BBIO
BridgeBio Pharma
Last Price:
26.16
Seasonality Move:
14.45%
Sell
27
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
- The current Intellia Therapeutics [NTLA] share price is $22.07. The Score for NTLA is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
BridgeBio Pharma (BBIO)
is a Sell
Is BridgeBio Pharma a Buy, Sell or Hold?
- The current BridgeBio Pharma [BBIO] share price is $26.18. The Score for BBIO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- BBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $22.07
The current trend is relatively stagnant and NTLA is experiencing buying pressure, which is a positive indicator for future bullish movement.
BBIO Stock Price Chart
What is BridgeBio Pharma's stock price today?
-
The BridgeBio Pharma share price today is $26.18
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing selling pressure, which indicates risk of future bearish movement.
NTLA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.76 | Sell |
| Relative Strength Index (14 RSI): | 50.13 | Buy |
| Chaikin Money Flow: | 1799902 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.8 - 23.22) | Buy |
| Bollinger Bands (100): | (21.69 - 25.41) | Sell |
BBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.71 | Buy |
| Relative Strength Index (14 RSI): | 45.21 | Sell |
| Chaikin Money Flow: | -2865693 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.18 - 28.96) | Sell |
| Bollinger Bands (100): | (24.97 - 28.75) | Sell |
NTLA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.61 | Buy |
| 20-day SMA: | 22.01 | Buy |
| 50-day SMA: | 23.42 | Sell |
| 200-day SMA: | 25.67 | Sell |
| 8-day EMA: | 21.03 | Buy |
| 20-day EMA: | 21.71 | Buy |
| 50-day EMA: | 22.78 | Sell |
| 200-day EMA: | 26.2 | Sell |
BBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.32 | Sell |
| 20-day SMA: | 27.13 | Sell |
| 50-day SMA: | 26.46 | Sell |
| 200-day SMA: | 30.08 | Sell |
| 8-day EMA: | 28.06 | Sell |
| 20-day EMA: | 27.49 | Sell |
| 50-day EMA: | 26.87 | Sell |
| 200-day EMA: | 27.51 | Sell |
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.06 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.20 per share.
BridgeBio Pharma Earnings Growth & BBIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.06 per share, an increase this year of $1.92 per share, and a decrease next year of $1.68 per share.
Intellia Therapeutics Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BridgeBio Pharma Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||